Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?

Gore L, Stelljes M, Quinones R.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S35-9. Erratum in: Semin Oncol. 2008 Feb;35(1):92. Stelljes, Mattias [corrected to Stelljes, Matthias].

PMID:
18086346
2.
3.

Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application.

Korycka A, Błoński JZ, Robak T.

Mini Rev Med Chem. 2007 Sep;7(9):976-83. Review.

PMID:
17897085
4.

Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.

Larson RA.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S13-20. Review.

PMID:
18086342
5.

Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies.

Furman RR, Hoelzer D.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S29-34. Review.

PMID:
18086344
6.

Pharmacology and mechanism of action of forodesine, a T-cell targeted agent.

Gandhi V, Balakrishnan K.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S8-12. Review.

PMID:
18086347
7.

The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.

Banerji V, Johnston JB, Seftel MD.

Transfus Apher Sci. 2007 Aug;37(1):57-62. Review.

PMID:
17919979
8.

Novel purine nucleoside analogues for hematological malignancies.

Korycka A, Lech-Marańda E, Robak T.

Recent Pat Anticancer Drug Discov. 2008 Jun;3(2):123-36. Review.

PMID:
18537755
9.

Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.

Tobinai K.

Semin Hematol. 2010 Apr;47 Suppl 1:S5-7. doi: 10.1053/j.seminhematol.2010.01.015. Review.

PMID:
20359583
10.

Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.

Ravandi F, Gandhi V.

Expert Opin Investig Drugs. 2006 Dec;15(12):1601-13. Review.

PMID:
17107284
11.

Older and new purine nucleoside analogs for patients with acute leukemias.

Robak P, Robak T.

Cancer Treat Rev. 2013 Dec;39(8):851-61. doi: 10.1016/j.ctrv.2013.03.006. Review.

PMID:
23566572
12.

Forodesine: review of preclinical and clinical data.

Al-Kali A, Gandhi V, Ayoubi M, Keating M, Ravandi F.

Future Oncol. 2010 Aug;6(8):1211-7. doi: 10.2217/fon.10.83. Review.

PMID:
20799866
13.

Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents.

Schramm VL.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):107-17. Review.

14.

Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

DeAngelo DJ.

Hematol Oncol Clin North Am. 2009 Oct;23(5):1121-35, vii-viii. doi: 10.1016/j.hoc.2009.07.008. Review.

PMID:
19825456
15.

Graft-versus-leukemia effects of transplantation and donor lymphocytes.

Kolb HJ.

Blood. 2008 Dec 1;112(12):4371-83. doi: 10.1182/blood-2008-03-077974. Review.

16.

Emerging drugs for acute graft-versus-host disease.

Khaled Y, Reddy P, Krijanovski O.

Expert Opin Emerg Drugs. 2009 Jun;14(2):219-32. doi: 10.1517/14728210903018891. Review.

PMID:
19519285
17.

Purine nucleoside phosphorylase inhibitors in T-cell malignancies.

Bantia S, Kilpatrick JM.

Curr Opin Drug Discov Devel. 2004 Mar;7(2):243-7. Review.

PMID:
15603259
18.

Mycosis fungoides: pathophysiology and emerging therapies.

Duvic M, Foss FM.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S21-8. Review.

PMID:
18086343
19.

Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.

Fielding AK, Banerjee L, Marks DI.

Curr Hematol Malig Rep. 2012 Jun;7(2):160-9. doi: 10.1007/s11899-012-0123-4. Review.

PMID:
22476945
20.

[Tight binding transition state analogues of purine nucleoside phosphorylase--meaning, design and properties].

Lewandowicz A.

Postepy Biochem. 2004;50(3):218-27. Review. Polish. No abstract available.

PMID:
15822751
Items per page

Supplemental Content

Support Center